Sunday, May 16, 2021 7:11:08 PM
As we approach a pivotal time for NWBO in the weeks ahead, attached are some slides that present a Market Capitalization for NWBO. This is a follow-up of my previous IHUB post on 12/27/20. This new model separates out DCVax- L and Direct. In addition, to simplify the analysis, a nGBM cancer rate of 3.42/100k of population while recurrent GBM is ignored (very conservative assumptions).
Based on my estimates, NWBO’s Market Cap could be in the range of US$15 billion to $30 billion.
I’ve been long on NWBO for many years.
Wishing all true NWBO longs success in their investment with this exciting technology.
Slide 1
Slide 2
Slide 3
Slide 4
Slide 5
Slide 6
Slide 7
Slide 8
https://investorshub.advfn.com/uimage/uploads/2021/5/16/rncizNWBO_Market_Model_Slide8.JPG
Recent NWBO News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
